Charter Trust Co. Has $332,000 Stake in Clorox Co (CLX)

Charter Trust Co. decreased its position in Clorox Co (NYSE:CLX) by 18.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,208 shares of the company’s stock after selling 484 shares during the quarter. Charter Trust Co.’s holdings in Clorox were worth $332,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Cornerstone Wealth Management LLC bought a new stake in shares of Clorox in the 2nd quarter worth about $105,000. Fort L.P. bought a new stake in shares of Clorox in the 2nd quarter worth about $129,000. Livingston Group Asset Management CO operating as Southport Capital Management bought a new stake in shares of Clorox in the 3rd quarter worth about $130,000. Ancora Advisors LLC bought a new stake in shares of Clorox in the 3rd quarter worth about $135,000. Finally, Legacy Advisors LLC bought a new stake in shares of Clorox in the 3rd quarter worth about $150,000. 77.96% of the stock is currently owned by institutional investors and hedge funds.

Shares of NYSE CLX opened at $162.47 on Friday. The stock has a market cap of $20.90 billion, a P/E ratio of 27.85, a P/E/G ratio of 4.02 and a beta of 0.30. The company has a debt-to-equity ratio of 3.38, a quick ratio of 0.65 and a current ratio of 1.07. Clorox Co has a 12-month low of $113.57 and a 12-month high of $167.70.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 31st. The company reported $1.62 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.59 by $0.03. The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.53 billion. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The firm’s quarterly revenue was up 4.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.46 EPS. On average, sell-side analysts forecast that Clorox Co will post 6.31 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, February 8th. Investors of record on Wednesday, January 23rd will be given a dividend of $0.96 per share. The ex-dividend date of this dividend is Tuesday, January 22nd. This represents a $3.84 annualized dividend and a yield of 2.36%. Clorox’s dividend payout ratio (DPR) is 61.34%.

In other Clorox news, COO Dawn C. Willoughby sold 25,950 shares of the company’s stock in a transaction dated Tuesday, December 4th. The shares were sold at an average price of $164.59, for a total transaction of $4,271,110.50. Following the transaction, the chief operating officer now directly owns 32,409 shares in the company, valued at approximately $5,334,197.31. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Benno O. Dorer sold 152,449 shares of the company’s stock in a transaction dated Tuesday, December 4th. The shares were sold at an average price of $164.83, for a total transaction of $25,128,168.67. Following the transaction, the chief executive officer now owns 111,735 shares in the company, valued at $18,417,280.05. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 265,851 shares of company stock worth $43,238,681. Corporate insiders own 1.40% of the company’s stock.

CLX has been the topic of several analyst reports. Wells Fargo & Co upped their target price on shares of Clorox from $135.00 to $145.00 and gave the stock a “market perform” rating in a report on Wednesday, October 17th. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $171.00 price target on the stock in a research report on Wednesday, October 3rd. Deutsche Bank downgraded shares of Clorox from a “hold” rating to a “sell” rating and set a $123.00 price target on the stock. in a research report on Wednesday, October 10th. Argus upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $175.00 price target on the stock in a research report on Tuesday, September 25th. Finally, Citigroup upped their price target on shares of Clorox from $149.00 to $153.00 and gave the stock a “neutral” rating in a research report on Friday, November 2nd. Five analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $144.93.

COPYRIGHT VIOLATION WARNING: This news story was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/12/08/charter-trust-co-has-332000-stake-in-clorox-co-clx.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: How Do You Calculate Return on Investment (ROI)?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply